CIK 0001100682 · Large accelerated filer
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Sign in to watch- Ticker
- CRL
- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 27
- Entity type
- operating
- EIN
- 061397316
- Phone
- 781-222-6000
- Business address
- 251 BALLARDVALE ST, WILMINGTON, MA, 01887
- Former names
- CHARLES RIVER LABORATORIES INTERNATIONAL INC, CHARLES RIVER LABORATORIES HOLDINGS INC
- 4/A Open-market sale CSVP&Chief Accounting Officer sold 808 shares at $267.52 ($216,156)
- 4 Shares withheld for taxes EVP & Chief People Officer gave up 379 shares (to pay taxes)
- SD Other Specialized Disclosure
- 4 Shares withheld for taxes Corporate Executive VP & CCO gave up 393 shares (to pay taxes)
- 4 Shares withheld for taxes CEVP, Disc & Safety Assessment gave up 343 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, Corp Strategy & Develop gave up 552 shares (to pay taxes)
- 4 Shares withheld for taxes Corporate Executive VP & COO gave up 750 shares (to pay taxes)
- 4 Planned sale Director sold 332 shares at an average $235.62 ($78,225)
- 4 Grant or award Director acquired 559 shares (grant or award)
- 4 Grant or award Director acquired 559 shares (grant or award)
- 4 Grant or award Director acquired 931 shares (grant or award)
- 4 Grant or award Director acquired 559 shares (grant or award)
- 4 Grant or award Director acquired 1,019 shares (grant or award)
- 4 Grant or award Director acquired 953 shares (grant or award)
- 4 Grant or award Director acquired 844 shares (grant or award)
- 4 Grant or award Director acquired 865 shares (grant or award)
- 4 Grant or award Director acquired 559 shares (grant or award)
- 4 Grant or award Director acquired 559 shares (grant or award)
- 144 Insider Sale of Securities
- 4 Open-market sale EVP, Corp Strategy & Develop sold 1,304 shares at $226.97 ($295,969)
Page 12 of 123 · 2,446 filings